Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01761760 · ClinicalTrials.gov registry record · NA

Videogame-based Incentives for Smoking Cessation

A NA study, sponsored by Rowan University.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT01761760: Clinical Trial NA study, sponsored by Rowan University.

NCT01761760 is a NA study that was terminated before completion, run by Rowan University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01761760, a NA study, was terminated before completion, sponsored by Rowan University.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Investigators will be evaluating an online video-game-based smoking cessation intervention that will overcome barriers to treatment such as cost and sustainability. This videogame will be the first of its kind, based on an evidence-based intervention shown to promote smoking abstinence. The findings from this research will be of great public health significance because of the unprecedented reach and relatively low cost, as well as the potential for similar interventions to be developed for other health problems, such as alcohol or drug abuse and medication adherence for chronic illnesses

Primary Outcome

Sustained abstinence will be collected via self-report

Interventions

  • BEHAVIORAL Videogame-based smoking cessation intervention

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2017-05-08
Est. Completion 2018-07-30
Phase NA
Rowan University

19 total trials

Why NCT01761760 stopped before completion

NCT01761760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Videogame-based smoking cessation intervention is the first listed.

NCT01761760 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01761760 about?

NCT01761760 is a clinical study titled "Videogame-based Incentives for Smoking Cessation". Investigators will be evaluating an online video-game-based smoking cessation intervention that will overcome barriers to treatment such as cost and sustainability. This videogame will be the first of its kind, based on an evidence-based intervention shown to promote smoking abstinence. The findings...

What is the current status of trial NCT01761760?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2017-05-08. Estimated completion is 2018-07-30.

What interventions are being tested in trial NCT01761760?

The interventions under investigation include: Videogame-based smoking cessation intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01761760?

This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01761760's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01761760, the US trial registry maintained by the National Library of Medicine. NCT01761760 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.